Sensei Biothera

$2.00 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Sensei Biothera

Sensei Biotherapeutics, Inc. operates as a clinical-stage immunotherapy company. The Company focuses in the discovery and development of next-generation therapies with an initial focus on treatments for cancer. Sensei Biotherapeutics serves customers in the United States.

Stock Analysis

last close $2.06
1-mo return 3%
3-mo return 28%
avg daily vol. 40.26T
52-week high 12.37
52-week low 1.45
market cap. $68M
forward pe -
annual div. -
roe -29.1%
ltg forecast -
dividend yield -
annual rev. $--
inst own. 21.7%

Subscribe now for daily local and international financial news